Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Virtual Domains d: A Survey of \Inundation and Ongoing interaction Mechanics\ Computer game - 2Figure out How to Keep up with Oral Wellbeing During Pregnancy
- 3As tetanus vaccination rates decline, doctors worry about rising case numbers
- 4Figure out How to Assess the Unwavering quality of SUVs for Seniors
- 54 injured in suburban Philadelphia nursing home explosion file negligence lawsuit
- Ukraine confirms defence and energy ministers at second attempt
- Supercharge Your Remote Work Arrangement with These Game-Changing Instruments
- 6 Well known Nissan Vehicles in the U.S.
- Eating ultra-processed foods could raise precancerous polyp risk for women under 50, according to research
- Select Your Cherished Fish
- Manual for Mountain Objections on the planet
- Luigi Mangione‘s lawyers say Bondi’s death penalty decision was tainted by conflict of interest
- Roche breast cancer pill cuts risk of disease recurrence by 30% in trial
- Executed Iranian nuclear scientist confessed to aiding Israel after torture, threats against mother
